Incorporating MOUD Treatment into Community Supervision

Held at the APPA 2024 Winter Training Institute, Seattle, Washington

Please complete this anonymous web-based survey prior to beginning the training.  You will be asked to do a follow up survey after finishing the training. 

This project was made possible through an agreement with the Justice Speakers Institute, LLC (JSI), and the American Probation and Parole Association.

The points of view expressed are those of the speakers and do not necessarily represent the official position or policies of the Louisiana Department of Public Safety and Corrections.

This training session is sponsored by Indivior.

 

 

APPA MOUD Training Pre-Questionnaire Survey

A Pre-Questionnaire for attendees of the APPA Medications for Opioid Use Disorder training.

1. Occupation (Please identify your position)(Required)

3. Is an Opioid Use Disorder (OUD) considered a disability under the American with Disabilities Act?(Required)
4. Is OUD a chronic disease?(Required)
5. Is it appropriate to make participation in a Medication Opioid Use Disorder (MOUD) program a requirement of supervision?(Required)
6. Does OUD impact the brain’s function?(Required)
7. Does MOUD treatment work the same way as alcohol antagonists?(Required)
8. Does MOUD treatment reduce cravings?(Required)
9. Can MOUD treatment improve criminal justice outcomes?(Required)
10. How familiar are you with Substance Use Disorders (SUD)?(Required)
11. How Familiar are you with OUD?(Required)
12. How familiar are you with MOUD?(Required)
13. How familiar are you with administering Naloxone/ Nalmefene Nasal Spray??(Required)
14. Rate how well your jurisdiction collaborates with Behavioral Health Professionals as part of wrap-around support services.(Required)
15. How familiar are you with best practices associated with supervising individuals with SUD/OUD?(Required)

Please rate the effectiveness of the below medications in treating OUD among the Justice-Involved individuals.

a. Oral Naltrexone(Required)
b. Injectable Naltrexone(Required)
c. Methadone(Required)
d. Oral Buprenorphine(Required)
e. Injectable Buprenorphine(Required)
f. Naloxone/ Nalmefene Nasal Spray(Required)

 

MENU

Copyright © 2022  Justice Speakers Institute, LLC.
All rights reserved.
The characteristics of honor, leadership and stewardship are integral to the success of JSI.

Therefore the Partners and all Associates subscribe to a Code of Professional Ethics.

JOIN US ON SOCIAL MEDIA

JUSTICE SPEAKERS INSTITUTE, LLC

P.O. BOX 20
NORTHVILLE, MICHIGAN USA 48167

CONTACT US

TOP

Get more information like this
in your inbox

Subscribe to our mailing list
and get interesting content and updates to your email inbox.

Thank you for subscribing.

Oops. Something went wrong.

We respect your privacy and take protecting it seriously